Clinical Trial Update: Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and treatment effect of QBECO in moderate-to-severe Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• QBECO

Snippet

Sponsor: Qu Biologics Inc. | Conditions: Crohn's Disease, Inflammatory Bowel Disease | Phase 1, Phase 2 | Status: COMPLETED